FSD Pharma Inc. ( HUGE) - Key Metrics
Stock symbol HUGE is outdated, potentially delisted? Maybe it is available on other exchange?
HUGE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q1 | ? | -$0.05 | -$0.05 | -$0.05 |
| 2023Q4 | ? | -$0.04 | -$0.02 | -$0.02 |
| 2023Q3 | ? | -$0.03 | -$0.04 | -$0.04 |
| 2023Q2 | ? | -$0.21 | -$0.09 | -$0.09 |
| 2023Q1 | ? | -$0.28 | -$0.12 | -$0.12 |
HUGE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q1 | ? | -235.16 |
| 2023Q4 | ? | -346.79 |
| 2023Q3 | ? | -681.59 |
| 2023Q2 | ? | -87.11 |
| 2023Q1 | ? | -90.13 |
HUGE
Price: $0.09
52 week price:
Earnings Per Share: -16.25 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 61417
Market Capitalization: 66671